Can I read Vedolizumab for Ulcerative Colitis Treatment on EtoBox?

Vedolizumab for Ulcerative Colitis Treatment by batai4 is a document available to read on EtoBox.

What is Vedolizumab for Ulcerative Colitis Treatment about?

Vedolizumab is recommended for treating moderately to severely active ulcerative colitis in adults, contingent upon a discount through the patient access scheme. Treatment should continue until it is ineffective or surgery is required, with reassessments at 12 months to determine ongoing clinical benefit. The drug is a humanized monoclonal antibody targeting gut inflammation, with a recommended dosage of 300 mg administered intravenously at specified intervals.

Author

batai4

Language

EN